Daily FNArena News - Australia

Navitas’ remains a longer term story but near term headwinds will keep earnings growth at bay.

Brokers welcome the acquistion by McMillan Shakespeare of second hand car finance company, further diversifying the company away from FBT risk.

Weekly Update on ASX-listed companies buying in their own stock.

Weekly update on recommendation, target price, and earnings forecast changes.

Fortescue Metals delivered robust FY15 production but given the current outlook for iron ore, most brokers are unsure as to whether margins can be maintained.

South32 delivered a solid June quarter production report but brokers keenly await details in the upcoming inaugural FY15 results.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Brokers may be somewhat divided on where the opportunities lie in the A-REITs sector but agree they are still to be found.

Sonic Healthcare is the second pathology provider to issue an earnings downgrade in a week, as funding cuts pressure the industry.